SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
X	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* LINTON JEFFREY D (Last) (First) (Middle) 5655 SPALDING DRIVE (Street) NORCROSS GA 30092 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol SEROLOGICALS CORP [ SERO ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) President Chemicon Division
	3. Date of Earliest Transaction (Month/Day/Year) 07/14/2006
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.01 Par Value	07/14/2006		D		10,918	D	$31.55	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Options (Right to Purchase)	$21.1	07/14/2006		D			20,000	(1)	05/15/2008	Common Stock, $0.01 par value	20,000	$31.55	0	D
Employee Stock Options (Right to Purchase)	$11.62	07/14/2006		D			17,500	(2)	05/15/2009	Common Stock, $0.01 par value	17,500	$31.55	0	D
Employee Stock Options (Right to Purchase)	$18.79	07/14/2006		D			19,250	(3)	05/14/2010	Common Stock, $0.01 par value	19,250	$31.55	0	D
Employee Stock Options (Right to Purchase)	$21.39	07/14/2006		D			29,819	(4)	05/11/2012	Common Stock, $0.01 par value	29,819	$31.55	0	D
Performance Units	$0.00	07/14/2006		D			4,962	(5)	12/31/2006	Common Stock, $0.01 par value	4,692	$31.55	0	D
Deferred Units	$0.00	07/14/2006		D			5,221	(6)	12/31/2006	Common Stock, $0.01 par value	5,221	$31.55	0	D
Restricted Units	$0.00	07/14/2006		D			1,791	(7)	07/14/2006	Common Stock, $0.01 par value	1,791	$31.55	0	D

Explanation of Responses:

1. Pursuant to merger agreement between issuer and Millipore Corp., vesting of this option was accelerated and was converted into the right to receive $209,000 in cash, which represents the difference between the exercise price and the merger considerations.

2. Pursuant to merger agreement between issuer and Millipore Corp., vesting of this option was accelerated and was converted into the right to receive $ 348,775 in cash, which represents the difference between the exercise price and the merger considerations.

3. Pursuant to merger agreement between issuer and Millipore Corp., vesting of this option was accelerated and was converted into the right to receive $245,630 in cash, which represents the difference between the exercise price and the merger considerations.

4. Pursuant to merger agreement between issuer and Millipore Corp., vesting of this option was accelerated and was converted into the right to receive $302,961 in cash, which represents the difference between the exercise price and the merger considerations.

5. Pursuant to merger agreement between issuer and Millipore Corp., vestig of these performance units was accelerated and were converted into the right to receive $156,551 in cash.

6. Represents deferred stock units from bonus. Pursuant to merger agreement between issuer and Millipore Corp., these deferred stock units were converted into the right to receive $164,723 in cash.

7. Represents restricted stock units. Pursuant to merger agreement between issuer and Millipore Corp., these restricted stock units were converted into the right to receive $56,506 in cash.

Remarks:

	/s/ Philip A. Theodore, Attorney in Fact for Jeffrey D. Linton	07/25/2006
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.